The 340B drug pricing program has long been a critical tool for community health centers, enabling them to stretch scarce resources and deliver affordable care to millions of patients—often in America’s rural and underserved communities. But today, this key healthcare funding lifeline is facing new challenges that could threaten its future.
In our latest episode of Community Health Centers. Unfiltered., ACH CEO and host Amanda Pears Kelly sits down with Elizabeth Lee, managing director of Continuum Health Group, to unpack the realities of the 340B program, how it works, why it matters, and what’s at stake if policy changes take hold.
Elizabeth Lee brings decades of experience working with health centers and safety net providers. In the discussion, she offers an insider’s perspective on how–without any taxpayers’ funding–the 340B program supports primary care for patients, access to life-saving medications, expanded services, and innovative care models. Together, Amanda and Elizabeth explore both the promise and the peril of this program at a time when community health centers and affordable healthcare are under increasing strain.
Take a Deep Dive into Why 340B Matters for Health Centers
Podcast listeners can find out:
- The original purpose of 340B and how it is an essential funding mechanism for health centers nationwide, without costing taxpayers.
- How patients and communities benefit when health centers can provide affordable medications and services.
- Why current policy debates could reshape affordable health center care and the future of safety net care.
- What leaders can do to prepare and advocate for their communities.
If you work at a health center, public health department, or any part of the healthcare safety net, this is a must-listen conversation. The stakes are high for health centers, and the millions of Americans who rely on CHCs for affordable, accessible care.
